Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
390.00    0.00 (0.00%)
Bid:
340.00
Ask:
420.00
Spread: 80.00 (23.529%)
Market Cap: £498.18m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Interim Management Statement

10 Dec 2009 09:53

RNS Number : 9028D
North Atlantic Smlr Co Inv Tst PLC
10 December 2009
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 OCTOBER 2009

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Financial Highlights

 
Cumulative performance
 
As at
31 October
2009
3 months
%
6 months
%
1 year
%
3 years
%
5 years
%
 
 
 
 
 
 
 
NAV *
 
 
 
 
 
 
 Basic
1,378p 
4.8
10.0
6.3
(20.5)
10.5
 Diluted
1,090p 
5.9
11.2
8.1
(8.4)
35.4
 
 
 
 
 
 
 
Mid-market price
781.5p 
(1.3)
15.4
21.2
(30.4)
4.9
 
 
 
 
 
 
 
Discount to diluted NAV *
28.3% 
 
 
 
 
 
 
 
 
 
 
 
 
Standard & Poor’s 500 Composite Index **
629.8
6.6
6.7
4.5
(12.8)
2.4
Russell 2000 **
 342.1
2.7
3.8
2.3
(14.9)
7.6
FTSE All-Share Index
2,584.6
9.8
18.9
18.4
(17.7)
12.5
US Dollar/Sterling exchange rate
1.6484
0.6
(11.2)
(2.0)
13.6
10.0

* Excluding retained revenue for the period.

** Sterling adjusted.

Material Events and Transactions During the Quarter

The Company was a party to the successful bid for Celsis International Plc during the quarter.

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2009

 
 
 
 
 
Castle Support Services Plc
UK Quoted on AIM
12.23
Oryx International Growth Fund Limited *
UK Listed
8.49
RPC Group
UK Listed
5.72
BBA Aviation Group Plc
UK Listed
5.14
Nationwide Accident Repair Services Plc
UK Quoted on AIM
4.33
Gleeson (M.J.) Group Plc
UK Listed
4.01
Norcliffe Investments Limited
UK Unquoted
4.00
Asset Co Limited Preference Shares
UK Unquoted
3.61
Trident Private Equity Fund II LP
Cayman Islands Unquoted
3.42
Bionostics Holdings Limited
USA Unquoted
3.41
 
 
 
% of total portfolio
 
54.36
 
 
 

* Incorporated in Guernsey

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2009

United 

United 

States 

Kingdom 

Europe 

Total 

General Industrials

1.7 

17.9 

19.6 

Investment Companies

0.6 

16.0 

16.6 

Support Services

1.5 

10.2 

1.2 

12.9 

Real Estate

4.4 

3.2 

7.6 

Health Care, Equipment & Services

0.8 

6.7 

7.5 

Travel & Leisure

5.2 

5.2 

Industrial Transportation

5.1 

5.1 

Manufacturing

4.3 

0.7 

5.0 

Construction & Materials

4.0 

4.0 

Industrial Engineering

3.9 

3.9 

Treasury Bills

3.4 

3.4 

Media

3.1 

3.1 

Communications

2.8 

2.8 

Technology Hardware & Equipment

1.2 

0.6 

1.8 

Oil & Gas

0.7 

0.5 

1.2 

General Financials

0.2 

0.2 

Food Producers

0.1 

0.1 

 

 

 

 

 

Total at 31 October 2009

14.4 

81.2 

4.4 

100.0 

Total at 31 January 2009

20.7

75.2

4.1

The financial information for the quarter ended 31 October 2009 contained within this Interim Management Statement has not been audited.

By order of the Board 

Bonita Guntrip for and on behalf of

J O Hambro Capital Management Limited as Company Secretary

10 December 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFGMMZLGDGLZG
Date   Source Headline
6th Aug 20259:57 amRNSTransaction in Own Shares and TVR
15th Jul 20259:34 amRNSNet Asset Value(s)
7th Jul 20251:00 pmRNSTransaction in Own Shares and TVR
7th Jul 202511:34 amRNSTransaction in Own Shares and TVR
19th Jun 20259:51 amRNSTransaction in Own Shares nad TVR
13th Jun 20253:52 pmRNSNet Asset Value(s)
12th Jun 20251:50 pmRNSShare Split and Total Voting Rights
12th Jun 20251:46 pmRNSResult of AGM
9th Jun 202510:45 amRNSTransaction in Own Shares and TVR
2nd Jun 20251:15 pmRNSTransaction in Own Shares and TVR
30th May 202511:01 amRNSTransaction in Own Shares and TVR
27th May 20253:26 pmRNSTransaction in Own Shares and TVR
23rd May 20251:44 pmRNSCompany Secretary Change
16th May 20257:00 amRNSNet Asset Value(s)
15th May 20257:00 amRNSAnnual Financial Report & Notice of AGM
7th May 20257:00 amRNSFinal Results
16th Apr 20257:00 amRNSNet Asset Value(s)
3rd Apr 202510:35 amRNSTransaction in Own Shares and TVR
31st Mar 20259:44 amRNSTransaction in Own Shares and TVR
24th Mar 20259:13 amRNSTransaction in Own Shares and TVR
18th Mar 20253:15 pmRNSNet Asset Value(s)
3rd Mar 20252:17 pmRNSTransaction in Own Shares and TVR
27th Feb 20257:00 amRNSDividend Declaration
17th Feb 202512:49 pmRNSTransaction in Own Shares and TVR
14th Feb 20259:26 amRNSNet Asset Value(s)
10th Feb 202511:05 amRNSTransaction in Own Shares and TVR
15th Jan 202511:10 amRNSDirector Declaration
15th Jan 202511:01 amRNSDirector Declaration
15th Jan 202510:39 amRNSNet Asset Value(s)
12th Dec 20241:48 pmRNSNet Asset Value(s)
29th Nov 202411:57 amRNSTransaction in Own Shares
25th Nov 202410:10 amRNSTransaction in Own Shares
15th Nov 202410:57 amRNSNet Asset Value(s)
11th Nov 202410:30 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 202411:50 amRNSNet Asset Value(s)
28th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 202411:51 amRNSInvestment Update: Performance Chemicals
3rd Oct 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSHalf-year Report - Replacement
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNet Asset Value(s)
14th Aug 202410:40 amRNSNet Asset Value(s)
26th Jul 202410:20 amRNSTransaction in Own Shares
25th Jul 202411:08 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20243:35 pmRNSTransaction in Own Shares
11th Jul 20247:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.